Welcome to the Cancer Research Institute blog. Here we share the latest updates on the field of cancer immunotherapy from CRI, including scientific breakthroughs, news stories, and program announcements. We invite your comments and encourage you to share these stories with your friends.
You can receive notifications of new posts by subscribing to our blog. Just click the RSS icon in the upper right corner.
September 4, 2014
Jill O'Donnell-Tormey, Ph.D.
Merck's new immunotherapy, Keytruda (pembrolizumab), was approved today by the FDA, making it the first PD-1 inhibitor cleared in the US.
August 22, 2014
| Matthew Tontonoz
A recent three-part series on CNN covers the exciting advances in cancer treatment being achieved by immunotherapy.
checkpoint-inhibitor, clinical trials, in the news, lung cancer, patients
June 14, 2013
| Audrey Tempelsman
A growing class of immune-based treatments cut the immune system's natural breaks—and save lives in the process.
checkpoint-inhibitor, CTLA-4, immunotherapy, ipilimumab, James Allison